Bryan White, PharmD, FIDSA, BCIDP
@bryanpwhite.bsky.social
📤 644
📥 598
📝 54
ID Pharmacist and PGY2 ID RPD in OKC at University of Oklahoma Medical Center
Excited to hear more details about the SNAP and CloCeBa trials for MSSA bacteremia being presented at ESCMID this afternoon. Looks like a win for team cefazolin. It will be practice changing with the current variations in practice for treating MSSA BSI.
#ESCMID
8 months ago
0
4
2
Our new paper on vancomycin AUC dosing in obesity is out. It showed decreased AKI in obese patients using AUC dosing as compared to trough dosing. Rates of AKI were lower in the AUC group compared to the trough group (11.3% versus 25.2%, p<0.001). This work was led by Corey Guidry .
loading . . .
https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofaf205/8105439?utm_source=advanceaccess&utm_campaign=ofid&utm_medium=email
8 months ago
1
4
3
The PGY2 in ID at OU didn’t match and is going into phase 2. Please help spread the word!
pharmacy.ouhsc.edu/programs/res...
loading . . .
Infectious Diseases - OU College of Pharmacy
https://pharmacy.ouhsc.edu/programs/residency/pgy2/infectious-diseases
9 months ago
0
1
2
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Joseph Sassine
10 months ago
Excited to launch new tracks in our 2-year ID fellowship program
@ou.edu
starting July 2025: TxID, Hospital epi/healthcare admin, Trop Med/Global Health, ID/Crit Care. Tracks come with option for 12-credit certificates, covered by the program:
medicine.ouhsc.edu/academic-dep...
🧵
#IDSky
#TxID
loading . . .
Curriculum
https://medicine.ouhsc.edu/academic-departments/internal-medicine/sections/infectious-diseases/infectious-diseases-fellowship/curriculum
1
3
1
Has anyone been using dalba as 12 weeks of treatment for PJI as per Daptio? Any recs or papers on this would be helpful.
#IDsky
10 months ago
1
0
0
Kinda of a crazy night. Went out for ice cream and ran into Oklahoma’s US senator, James Lankford. Talked for 2 minutes about RFK. Nice conversation with a thoughtful politician.
#IDsky
10 months ago
1
4
0
reposted by
Bryan White, PharmD, FIDSA, BCIDP
10 months ago
PLEASE SHARE WIDELY
#medsky
#IDsky
#obgynsky
#pedsky
CDC STI treatment guidelines have been taken down. They are archived here 👇
web.archive.org/web/20250131...
loading . . .
Site Index
STIs are common. Many are curable - all are preventable.
https://web.archive.org/web/20250131223812/https://www.cdc.gov/sti/site.html
0
15
7
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Joseph Marcus
10 months ago
Post-hoc analysis of 📷 📷 study in MSSA/MRSA bacteremia: Persistent fever = indicator for complicated infection Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7) 🚫 assn between ⬆️CRP/WBC and mortality
#IDSky
academic.oup.com/ofid/advance...
loading . . .
Association of daily body temperature, white blood cell count, and C-reactive protein with mortality and persistent bacteremia in patients with Staphylococcus aureus bacteremia: a post-hoc analysis of...
AbstractIntroduction. Classification of patients with Staphylococcus aureus bacteremia (SAB) as complicated versus uncomplicated is based on a combination
https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofaf063/7990839
2
37
14
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Liv Swonger, PharmD
11 months ago
There is a director of pharmacy position open at Bartlett Regional Hospital in Juneau, Alaska. Oversees ~25 rx employees in a 55 bed hospital in Alaska's capital and largest town in Southeast Alaska. I work there several times a year, happy to answer any questions. Spread far and wide!
2
4
3
This time of the year is exciting as a RPD to review the packets from great candidates who are excited to learn more.
#pharmsky
11 months ago
0
2
0
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Tired Pharmacist
11 months ago
Pharmacy fun fact! You need to be very careful when handling metronidazole. It’s flagyl
#medsky
#pharmsky
2
9
1
reposted by
Bryan White, PharmD, FIDSA, BCIDP
JAC-AMR
11 months ago
A retrospective cohort study of Gram-negative BSIs in ICU shows fever, lack of source control and time to repeat follow-up blood culture (FUBC) as risk factors for repeat positive FUBC:
https://doi.org/10.1093/jacamr/dlae144
#JACAMRNews
@bryanpwhite.bsky.social
loading . . .
Risk factors for positive follow-up blood cultures in critically ill adults with Gram-negative bacteraemia
AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify
https://doi.org/10.1093/jacamr/dlae144
0
3
2
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Erin McCreary, PharmD
12 months ago
UPMC Western Maryland is looking for a full time stewardship pharmacist. Come work with a truly amazing local team and have system support from Tina Khadem, myself, and ~40 other pharmacists! (also - no holidays, no weekends!)
#idsky
#amssky
#pharmsky
#medsky
sidp.mcjobboard.net/jobs/173869
loading . . .
Infectious Disease Clinical Pharmacist Specialist
UPMC Western Maryland is seeking a highly motivated Infectious Disease Clinical Pharmacist to lead its Antimicrobial Stewardship Program. UPMC Western Maryland is a 224-bed nonprofit, acute care hospi...
https://sidp.mcjobboard.net/jobs/173869
1
17
7
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Antibiotic Steward 🅱️C🆔🅿️🌟
12 months ago
🔥🆕️CACTUS Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia Overall similar clinical success including mortality, recurrent infection & resistance
#idsky
#EMIMCC
#medsky
www.thelancet.com/journals/lan...
loading . . .
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
Treatment with ceftolozane–tazobactam resulted in higher rates of clinical success compared with ceftazidime–avibactam for invasive infections due to multidrug-resistant P aeruginosa. Differences were driven by improved response rates for patients with pneumonia who were treated with ceftolozane–tazobactam. There were no significant differences between study groups with respect to all-cause mortality; treatment-emergent resistance was common with both agents.
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00648-0/abstract
1
22
11
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Joseph Sassine
12 months ago
First post on
#IDSky
We have an ID fellowship opening at the University of Oklahoma
@ou.edu
, starting July 2025. Two-year program, with great exposure to HIV, transplant ID and surgical infections, and above all, great people to train with! DM me for details!
medicine.ouhsc.edu/academic-dep...
loading . . .
Fellowship Opportunities
https://medicine.ouhsc.edu/academic-departments/internal-medicine/sections/infectious-diseases/infectious-diseases-fellowship/fellowship-opportunities
0
33
15
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Julie Ann Justo
12 months ago
I’m in! 🙋🏻♀️ Who else in
#IDsky
#Pharmsky
#AMSsky
is going?
@sidpharm.bsky.social
add a skeleton here at some point
0
4
1
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Sanford Guide
12 months ago
Pre-exposure prophylaxis (PreP) is an effective strategy to prevent HIV infection. However, lack of adherence to daily oral therapy is a major reason for failure in preventing HIV infection. Read about two large RCTs on twice-yearly lenacapavir
https://buff.ly/3OTO5CE
#HIVsky
#IDsky
0
7
3
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Athena Hobbs
12 months ago
Having a blast learning at ASHP (with
@bryanpwhite.bsky.social
) and exploring NOLA-Sazerac house, City Park lights
0
5
1
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Justin Moore
12 months ago
Great ID expert session on optimal invasive Candidiasis diagnostics & mgmt from
@bryanpwhite.bsky.social
& Daniel Chastain at
#ASHP24
0
5
1
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Justin Moore
12 months ago
Wonderful insight from
@athenalvhobbs.bsky.social
&
@bryanpwhite.bsky.social
on oral therapies for bloodstream infections due to a urinary source at ASHP! Pop girlies & ID unite for the TSwift support of PO! 💞💊
#ASHP24
2
7
1
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Sébastien Poulin
12 months ago
The « meme master » is here
@iddocadi.bsky.social
(IDdocAdi, Adi S. Shah)
#IDsky
#Medsky
3
21
5
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Lisa Dumkow, PharmD, BCIDP, FIDP
12 months ago
🚨📣
@sidpharm.bsky.social
the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday:
www.cognitoforms.com/SIDP1/_2025S...
0
8
6
reposted by
Bryan White, PharmD, FIDSA, BCIDP
SHORTEN-2 trial
about 1 year ago
What's the best duration for treating uncomplicated P. aeruginosa-BSI? This metaanalysis of observational studies (n=1746) found no differences in recurrence+mortality for short (<10d) compared to prolonged treatments. 📖
www.journalofhospitalinfection.com/article/S019...
#PsWatch
#AMSsky
#IDsky
1
9
6
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Megan Seddon
about 1 year ago
🧵of beta-lactam antibiotic learning points I developed for learners on rotation. Feedback welcome - there are a ton of brilliant people here who do really cool science in these areas. Would love to learn more! Hope you enjoy this learner-🎯tweetorial
#IDSky
#PharmSky
#PharmEd
#MedEd
1/n
7
43
18
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Zack (Snacks) Nelson, PharmD, MPH
about 1 year ago
What did I do this morning? Fill out quick surveys about CDI! They’re quick and support very important research!
#IDSky
redcap.link/guubtkxs
@connorprosty.bsky.social
@drtoddlee.bsky.social
@dremilymcd.bsky.social
loading . . .
Prophylaxis, Diagnosis, and Management of Clostridioides difficile Infections: An International Cross-Sectional Survey of Clinicians
https://redcap.mchi.mcgill.ca/surveys/?s=X4XWRXLDWKELW9MC
2
6
3
Medicine in 2024: emojis on the fax cover sheet.
#IDsky2024
about 1 year ago
1
4
1
reposted by
Bryan White, PharmD, FIDSA, BCIDP
David van Duin
about 1 year ago
Great to see BALANCE trial published! Large RCT of >3,000 patients, >50% in ICU, 7 days non-inferior to 14 days for (mostly) GNR BSI. Solid-organ/stem-cell transplant & neutropenia were excluded. Note: 24% in 7d group received longer duration
#IDSky
#TxIDSky
www.nejm.org/doi/full/10....
loading . . .
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM
Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In a multicenter, non...
https://www.nejm.org/doi/full/10.1056/NEJMoa2404991
3
52
14
reposted by
Bryan White, PharmD, FIDSA, BCIDP
Antibiotic Steward 🅱️C🆔🅿️🌟
about 1 year ago
🔥SNAP passed 3500🔥 Writing papers: Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox Recruiting: Adj clinda vs not (all) Adj cefazolin vs not (MRSA) Oral switch vs IV (all) Cefazolin +/- Erta/Placebo (MSSA) Dapto vs Vanco (MRSA) Coming "soon": Rifampin vs. none for PVIE (all) Ref: Dr.Lee
#idsky
2
32
14
OPAT and PWID, even with the data on it being safe there is still stigma. There are so many different stakeholders along the way who can veto patients getting the care they need.
#IDSky
about 1 year ago
0
3
0
reposted by
Bryan White, PharmD, FIDSA, BCIDP
FungalDoc AKA Andrej Spec
about 1 year ago
It is time. Twitter/X is dying and it is time to move here.
4
56
7
reposted by
Bryan White, PharmD, FIDSA, BCIDP
ID:IOTS Podcast
about 1 year ago
Oh I feel as we’re on a new platform I should announce: I’m a podcast! Infectious Disease: Insight Of Two Specialists (ID:IOTS) is the UK’s Prémièrẽ infectious disease podcast! We’ve been going for about 3 years now, and are aimed at educating early years ID/Micro trainees in the UK, but 1/x
2
53
8
Hello
#IDsky
, I’m giving this a try after being on IDtwitter for a bit. I’m an ID pharmacist in OKC interested in stewardship, OPAT, and lots of general ID things.
about 1 year ago
0
15
2
you reached the end!!
feeds!
log in